Soo Heon Kwak
Overview
Explore the profile of Soo Heon Kwak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
3496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee H, Fernandes M, Lee J, Merino J, Kwak S
Diabetologia
. 2025 Mar;
PMID: 40088285
Diabetes is a rapidly growing global health concern projected to affect one in eight adults by 2045, which translates to roughly 783 million people. The profound metabolic alterations often present...
2.
3.
Son H, Sohn S, Kim H, Choe H, Lee H, Jung H, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):1836-1844.
PMID: 39776241
Background: Effective glycaemic control following cardiac surgery improves clinical outcomes, and continuous glucose monitoring (CGM) might be a valuable tool in achieving this objective. We investigated the effect of real-time...
4.
Yoo J, Jun J, Kwak S, Kim J
J Diabetes Sci Technol
. 2025 Jan;
:19322968241306136.
PMID: 39754348
Background: We evaluated the efficacy of structured individualized education combined with real-time continuous glucose monitoring (rt-CGM, Dexcom G6) in improving glycemic outcomes in insulin-treated adults with poorly controlled type 2...
5.
Baek S, Park J, Chung J, Kwak S, Yoon S
Diabetes Obes Metab
. 2024 Dec;
27(3):1580-1583.
PMID: 39639838
No abstract available.
6.
Moon J, Won S, Won H, Son H, Oh T, Kwak S, et al.
Endocrinol Metab (Seoul)
. 2024 Nov;
PMID: 39604803
Background: Gestational diabetes mellitus (GDM) affects women with diverse pathological phenotypes, but little is known about the effects of this variation on perinatal outcomes. We explored the metabolic phenotypes of...
7.
Lee W, Song Y, Chun J, Ko M, Jang H, Kim I, et al.
Diabetes Res Clin Pract
. 2024 Oct;
217:111897.
PMID: 39428040
Aims: To develop a machine learning model for predicting rapid kidney function decline in people with type 2 diabetes (T2D) and chronic kidney disease (CKD) and to pinpoint key modifiable...
8.
Seo Y, Kang I, Lee H, Hwang J, Kwak S, Oh M, et al.
Anal Bioanal Chem
. 2024 Oct;
416(29):7007-7018.
PMID: 39422715
Clinical proteomics has substantially advanced in identifying and quantifying proteins from biofluids, such as blood, contributing to the discovery of biomarkers. The throughput and reproducibility of serum proteomics for large-scale...
9.
Park C, Choi J, Kwak S, Lee S, Kim H, Kim Y, et al.
BMJ Open Diabetes Res Care
. 2024 Sep;
12(4).
PMID: 39256051
Introduction: Various strategies aim to better assess risks and refine prevention for patients with type 2 diabetes mellitus (T2DM), who vary in cardiovascular disease (CVD) risk. However, the prognostic value...
10.
Kim N, Lee J, Chon S, Yu J, Jeong I, Lim S, et al.
Endocrinol Metab (Seoul)
. 2024 Aug;
39(5):722-731.
PMID: 39174014
Backgruound: Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia...